Cannabis Science, Inc. is a medical marijuana research and development company. The Company works on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. It is focused on developing cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance. The Company has two subsidiaries: The Company formed two operating subsidiaries Cannabis Science BV and Cannabis Science International Holding BV. The Company has partnered with propagators and laboratories for extractions, analytical development and clinical trial implementation. It uses an inquiring approach to discover and develop cannabinoid-based therapies.